Cytoprotection and iron mobilization in rat hepatocyte cultures by a new synthetic dihydroxamate chelator

Toxicology Letters

Volumn 110, Issue 1-2, 1999, Pages 19-27

  Rakba, N ^a   Nguyen Van Duong, M K ^b   Nicolas, L ^b   Guillot, V ^b   Morel, I ^a   Pasdeloup, N ^a   Brissot, P ^a   Lescoat, G ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

Dihydroxamate chelator; Iron toxicity; Rat hepatocytes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHELATING AGENT; DEFEROXAMINE; ETHANE; FERRIC CITRATE; LACTATE DEHYDROGENASE; MALONALDEHYDE;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ENZYME RELEASE; IRON KINETICS; IRON OVERLOAD; IRON TRANSPORT; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORING AGENTS; HYDROXAMIC ACIDS; IRON; IRON CHELATING AGENTS; IRON RADIOISOTOPES; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLIUM SALTS; THIAZOLES;

ANIMALIA;

EID: 0032717297     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00135-6     Document Type: Article

References (27)

1. Agarwal M.B., Gupte S.S., Viswanathan C., Vasandani D., Ramanathan J., Desai N., Puniyani R.R., Chablani A.T. Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion-dependent thalassaemia: Indian trial. Br. J. Haematol. 82:1992;460-466.
2. Azari P., Baugh R.F. A simple and rapid procedure for preparation of large quantities of pure ovotransferrin. Arch. Biochem. Biophys. 118:1967;138-144.
3. Batey F.G., Lai Chung Fong P., Shamir S., Sherlock S.A. A non transferrin bound serum iron in idiopathic hemochromatosis. Dig. Dis. Sci. 25:1980;340-346.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Brissot P., Wright T.L., Ma W.L., Weisiger R.A. Efficient clearance of non-transferrin bound iron by rat liver. Implications for hepatic iron loading in iron overloaded states. J. Clin. Invest. 76:1985;1463-1470.
6. Brissot, P., Deugnier, Y., 1998. Genetic haemochromatosis. In: McIntyre, N., Benhamou, J.P., Bircher, J., Rizetto, M., Rodes, J. (Eds.), Oxford Textbook of Clinical Hepatology, vol. 2, second ed. Oxford University Press (in press).
7. Brissot, P., Loréal, O., Hubert, N., Morel, I., Jouanolle, H., Moirand, R., Guyader, D., Lescoat, G., Deugnier, Y., 1992. Chronic metal overload and hepatic damage. In: Clément, B., Guillouzo, A. (Eds.), Cellular and Molecular Aspects of Cirrhosis, vol. 216. Les Editions INSERM, John Libbey Eurotext Paris, pp. 13-23.
8. Chenoufi N., Hubert N., Loréal O., Morel I., Pasdeloup N., Cillard J., Brissot P., Lescoat G. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94. J. Hepatol. 23:1995;166-173.
9. Cohen A.R., Martin M., Schwartz E. Depletion of excessive liver iron stores with desferrioxamine. Br. J. Haematol. 58:1984;369-373.
10. Csallany A.S., Guan D.M., Manwaring J.D, Addis P.B. Free malondialdehyde determination in tissues by high performance liquid chromatography. Anal. Biochem. 142:1984;277-283.
11. Deugnier Y., Loréal O., Turlin B., Guyader D., Jouanolle H., Moirand R., Jacquelinet C., Brissot P. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 102:1992;2050-2059.
12. Guguen C., Guillouzo A., Boisnard M., Le Cam A., Bourel M. Etude ultrastructurale de monocouches d'hépatocytes de rat cultivés en présence d'hémisuccinate d'hydrocortisone. Biol. Gastroenterol. 8:1975;223-231.
13. Hershko C., Graham C., Bates G.W., Rachmilewitz E.A. Non specific serum iron in thalassemia: an abnormal serum fraction of potential toxicity. Br. J. Haematol. 40:1978;255-263.
14. Hider R.C. Potential protection from toxicity by oral iron chelators. Toxicol. Lett. 82-83:1995;961-967.
15. Hubert N, Lescoat G., Sciot R., Moirand R., Jégo P., Leroyer P., Brissot P. Regulation of ferritin and transferrin receptor expression by iron in human hepatocyte cultures. J. Hepatol. 18:1993;301-312.
16. f, the siderophore of Pseudomonas fluorescens. Biochem. Pharmacol. 43:1992;1275-1280.
17. a, the siderophore of Pseudomonas aeruginosa. Toxicol. In Vitro. 7:1993;55-60.
18. Kontoghiorghes G.J. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs. Toxicol. Lett. 80:1995;1-18.
19. Loréal O., Deugnier Y., Moirand R., Lauvin L., Guyader D., Jouanolle H., Turlin B., Lescoat G., Brissot P. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron related factors in 127 homozygous patients. J. Hepatol. 16:1992;122-127.
20. Morel I., Lescoat G., Cillard J., Pasdeloup N., Brissot P., Cillard P. Kinetic evaluation of free malondialdehyde and enzyme leakage as indices of iron damage in rat hepatocyte cultures: involvement of free radicals. Biochem. Pharmacol. 39:1990;1647-1655.
21. Nyugen-Van-Duong M.K., Nicolas L., Gaudemer A., Brik M.E. Synthesis and ESR study of new dihydroxamic acid siderophores as scavengers of hydroxyl radicals. Bioorg. Med. Chem. Lett. 8:1998;227-232.
22. Olivieri N.F., Brittenham G.M., Matsui D. et al. Iron-chelation therapy with oral deferiprone in patients with thalassaemia major. N. Engl. J. Med. 332:1995;918-922.
23. Porter J.B., Huehns E.R. The toxic effects of desferrioxamine. Bailliere's Haematol. 2:1989;459-474.
24. Rakba N., Aouad F., Henry C. et al. Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox. Biochem. Pharmacol. 55:1998;1797-1806.
25. Schafer A.I., Cheron G., Dluhy R., Cooper B., Gleason R.E., Soeldner J.S., Bunn H.F. Clinical consequences of acquired transfusional iron overload in adults. N. Engl. J. Med. 304:1981;319-324.
26. 2+ on enzymatic dispersion of isolated perfused liver. Exp. Cell. Res. 74:1972;450-454.
27. Twentymann P.R., Luscombe A. Study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer. 56:1987;279-285.